Better Future Initiative in Pharmaceutical | Analysis

Running head: COMPARE CONTRAST ESSAY
BETTER FUTURE INITIATIVE IN PHARMACEUTICALS - PSA 2023 OR PGA 2025
Name of Student
Name of University
Author note

BETTER FUTURE INITIATIVE IN PHARMACEUTICALS - PSA 2023 OR PGA 2025
1
Introduction
Pharmacological management involves the right prescription and the right
administration of the medications, appropriate to the clinical condition of the patients in the
health care scenario (Bush et al., 2018). The shortage of medications and misuse plus disuse
of medications play a huge role in the presentation of the adverse medication incidents which
is the center focus of the ‘Pharmacists in 2023’ and the ‘Community pharmacy 2025’. Safety
issues are always very risky and there is an increased prevalence of safety issues related to
medications, in the health care system dealing with a high paced clinical environment (Eassey
et al., 2016). The business programs ‘Pharmacists in 2023’ and ‘Community pharmacy 2025’
that is to discussed and contrasted play a huge role in empowering the rights of the
pharmacists with respect to counseling, medication reconciliation, disease state management
to phramacovigilance, antimicrobial stewardship and discharge management in the hospitals
as well (Clayton, Luxford & Stupans, 2017). Due to lack of specialty healthcare in the
community areas, the role and the scope of practice of the pharmacists has been extended as
well in order to play a part in health care delivery with respect to disease conditions such as
asthma, diabetes and hypertension management, osteoporosis screening, arthritis and
cardiovascular management, mental health problems and palliative care as well. In this essay,
the two plans that are to be compared and contrasted are ‘Pharmacists in 2023’ and the
‘Community pharmacy 2025’ that are based in the health care system of Australia. While the
services and structures of the two plans differs at various aspects, there are similarities too
that build up the compare and contrast discussion. The aspects identified are Actions for
change, Strategies for workforce development, Medication safety process, Health care service
delivery process, Digitization process. Both the programs will continue to play a huge part in
extension of the pharmacological scope of practice from clinical phramacovigilance to the

BETTER FUTURE INITIATIVE IN PHARMACEUTICALS - PSA 2023 OR PGA 2025
2
important disciplinary part to be played in the clinical pathways and community based
services.
Statistical analysis
Workforce development and infrastructural development are critical aspects of the
delivery of the pharmaceutical care to community, health hubs and other rural areas. With the
right application of the strategies and the knowledge along with the resources – abilities and
capacities of the workforce can be enhanced. The use and application of the diverse roles of
the pharmacists across the different or rather a very wide range of settings has been
considered and empowered by both the above mentioned health management plans but the
ways and components of the workforce strategies are different in both the plans. Continuous
professional developed development, safe and quality patient centered service delivery, use
and application of the of health information technology, digitization and training the staffs in
communication and on the effective ways of the customer counseling are the major areas that
has been more or less covered by both the business plans (Chevalier et al., 2020). As both the
plans targets at delivering care to community areas, the workforce development has been
focused on developing partnerships with the community members and both the projects
undertakes an extensive market research to understand the exact need of exact communities
in order to empower the pharmacists and the other supporting staffs in the responded areas.
“Pharmacists in 2023” provides 11 actions for health change that are identified. The actions
pertains to the promotion of the medicine safety; improving the pharmacy oriented heath care
through the ease provided and extended by digital transformation; by collaborating with the
community pharmacy; by aiding the collaboration of pharmacists with the clinicians of care
teams; prescribing the right and appropriate medications (Jackson, 2019). Facilitating smooth
transitions of care stages and processes is another critical action. Working integrated with the
health hubs, staff development, funding, delivering service to the rural and remote followed

BETTER FUTURE INITIATIVE IN PHARMACEUTICALS - PSA 2023 OR PGA 2025
3
by continuous research and evaluation of outcomes are the major actions as well. On the
other hand, the “Community Pharmacy 2025” provides 9 actions. These are recovery oriented
and quality health services; proper delivery of substantial and effective medication and other
health services to the community health hub. Digital enablement in regards to the knowledge
delivery and creating awareness about the right application of medications and incorporating
the important components of digitization in the business operations are the other critical
actions (Chevalier et al., 2018). The other components includes ‘in-home care’, collaboration
and partnerships of the pharmacists and the relevant staffs with other members of the
multidisciplinary team and with the community leaders, Automation of the processes,
leveraging the brand and undertaking a comprehensive review of the products are the other
important components of this health care business project.
In “Pharmacists in 2023” plan, for workforce development, there are 13 mentioned
strategies that involve the improvement of the academic capacity, enhancing the foundation
of the staff training, improving the parameters of quality assurance, aiding in the
development and advancement of the specialists, aiding in the competency development,
helping staffs and providing equal opportunity to everyone in leadership development,
service provision and workforce, enhancing the interpersonal communication and
collaboration in order to facilitate effective working with other members of the health care
service delivery team (Sims, 2019). The strategies also involve the development of the
continuous professional development strategies, ethical considerations balancing the diversity
and gender difference, evaluating the impact of the workforce, measuring the workforce
intelligence and formation of the right and accurate set of the workforce policies. In the
“Community Pharmacy 2025” health care project, there are twelve workforce development
strategies that focuses on 12 components such as the curriculum that is to be taught to the
pharmacists, training and development of the pharmacy staffs and interns as well as of the